Access cutting-edge alopecia areata treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access alopecia areata specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alopecia areata treatment provided free
This study evaluates the safety and effectiveness of deuruxolitinib in adolescents aged 12 to less than 18 years who have 50% or greater scalp hair loss.
Sponsor: Sun Pharmaceutical Industries, Inc.
Check if you qualify for this alopecia areata clinical trial in Indianapolis, IN
If you're searching for alopecia areata treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alopecia areata specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.